Suffolk Capital Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-71,511
Closed -$634K – 144
2017
Q4
$634K Sell
71,511
-51,298
-42% -$473K 0.08% 112
2017
Q3
$1.37M Sell
122,809
-76,760
-38% -$747K 0.18% 74
2017
Q2
$1.79M Buy
199,569
+21,621
+12% +$172K 0.24% 71
2017
Q1
$1.4M Buy
177,948
+15,987
+10% +$130K 0.19% 95
2016
Q4
$1.39M Buy
+161,961
New +$1.39M 0.19% 107

Other funds holding NEO

Suffolk Capital Management's NEO Position: Q1 2018 in Review

Suffolk Capital Management sold out of NeoGenomics (NEO) in Q1 2018, closing a stake of 71,511 shares — an estimated $634K sold.

Suffolk Capital Management first reported a position in NEO in Q4 2016 and held it in 5 quarters. The position peaked at $1.79M in Q2 2017. 137 funds tracked by Wall St. Rank hold NEO as of Q1 2018.

  • Suffolk Capital Management reported no remaining NeoGenomics position as of Q1 2018 after selling out during the quarter.
  • Suffolk Capital Management sold 71,511 NeoGenomics shares in Q1 2018, an estimated $634K.
  • Suffolk Capital Management first reported a position in NeoGenomics in Q4 2016 and held it in 5 quarters.
  • Suffolk Capital Management's NeoGenomics position peaked at $1.79M in Q2 2017.
  • 137 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2018.

Based on Suffolk Capital Management's 13F filing for Q1 2018, filed 7 May 2018.